Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/14/1258   
Active ingredient: Doxorubicin(6-maleimidocaproyl)hydrazone
Indication: Treatment of soft tissue sarcoma
Sponsor: Pharma Gateway AB
Johanneslundsvägen 2, 194 61 Upplands Väsby, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/03/2014 Orphan designation EMA/OD/190/13 (2014)2116 of 26/03/2014
27/03/2015 Transfer of orphan designation EMA/OD/190/13/T/01 (2015)2217 of 25/03/2015
13/06/2017 Change of name and/or address of sponsor